Navigation Links
InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
Date:9/12/2011

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to the commercial launch for Esbriet® (pirfenidone) in Germany and other countries in the EU, and statements regarding timing of the ASCEND trial enrollment.  All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information.  InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.  

Other factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the Securities and Exchange Commission (SEC) (the "Form 10-K"), and other periodic reports filed with the SEC, including but not limited to the following: (i) risks related to our ability to successfully launch and commercialize Esbriet in the EU, including successfully establishing a commercial operation in the EU and receiving favorable governmental pricing and reimbursement approvals in each EU country; (ii) risks related to the regulatory process for the company's product candidates, including the possibility that the results of the new 52-week Phase 3 clinical trial (ASCEND) having an FVC endpoint may not be satisfactory to the FDA for InterMune to receive regulatory approval for pirfenidone in the United States; (iii) risks related to the uncertain, lengthy and expensive clinical development process for the company's product candidates, including having no unexpected safety, toxicology, clinical or other
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
2. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
3. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
4. InterMune to Present at J.P. Morgan Healthcare Conference
5. InterMune Reports Third Quarter 2010 Financial Results
6. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
7. InterMune to Release Second Quarter Financial Results on July 27
8. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
9. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
10. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
11. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... AMBLER, Pa. , Sept. 29, 2014 /PRNewswire/ ... approval for the CNS Monitor, a medical device ... patients. The CE Mark certifies that a product ... in Europe . ... parameters including electroencephalography (EEG, or brain waves) to ...
(Date:9/29/2014)... , Sept. 29, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... to its Board of Directors from Engaged Capital, ... response:  Volcano welcomes the perspectives ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "EU5 Sigmoidoscopes Market ... the EU5 Sigmoidoscopes market. The report provides value, ... and average prices (in US dollars) within market ... (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc. ... has executed a new senior credit agreement with Bank of ... its revolving line of credit to $10 million, which is ... the new facility has been extended to December 2014. ...
... Purdue Pharma, L.P., a privately held pharmaceutical ... International , a U.S.-based humanitarian organization that helps ... view the multimedia assets associated with this release, ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ) Purdue ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:9/29/2014)... (PRWEB) September 30, 2014 NAPW ... Family Therapist at Heaven Sent Consultation , as ... is recognized with this prestigious distinction for leadership in ... organization of professional women in the country, spanning virtually ... Women is a powerfully vibrant networking community with over ...
(Date:9/29/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Top10BestSEOHosting.com has recently compared many Linux ... ) and Bluehost are the most recommended suppliers ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the oldest ... was worn by a man, Ötzi the Iceman. In ... direction of using small ornamental purses—which evolved into handbags—men's ... leading online supplier of fashion accessories, has released its ... fashionable. , For most men, they do not ...
(Date:9/29/2014)... York, NY (PRWEB) September 29, 2014 ... Some parents get lucky when there little one can slumber ... and takes consistent naps each day. For many parents, the ... perform if you're exhausted and consumed with stress. After ... assumed that like other babies she would fall asleep ...
(Date:9/29/2014)... (PRWEB) September 29, 2014 Dr. Robert ... over 25 years in his hometown, returns to Houston ... Neurosurgical and Spine Center. , Over the last nine ... Army Hospital at Fort Hood and Lubbock. He will ... Neurosurgical Excellence devoted to the goal of excellence in ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Carmel T. Ross, Marriage and Family Therapist at Heaven Sent Consultation, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 3Health News:Houston Neuro & Spine Surgery Plans to Develop Center of Neurosurgical Excellence 2
... of the acclaimed general surgical reference, ACS Surgery, is honored to ... new Editor-in-Chief , ... Philadelphia, PA (PRWEB) March 11, ... reference, ACS Surgery, is honored to announce the appointment of Stanley ...
... 72 hours.,* Health insurance agents and brokers can also receive training ... , ... Chicago, IL (PRWEB) March 11, 2009 -- Norvax ... on Thursday, March 26, just a month after its "standing room ...
... will perform a PPP laser procedure on The Doctors ... for airtime. SANTA CLARA, Calif., March 10 Lumenis ... light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic ... featured on The Doctors national television show on Tuesday, ...
... New research released to mark No Smoking Day (11 ... smokers in Great Britain are thinking,about or planning to cut down ... also shows that one in ten (9%) will be taking the ... No Smoking Day President and Dragons, Den ...
... TUESDAY, March 10 (HealthDay News) -- Used together, a blood ... detecting ovarian cancer in its early and more curable stages, ... a new standard in the fight against this deadly and ... be an approach that may be workable," said Robert Smith, ...
... 2010 state budget maintains charity care spending levelMARLTON, N.J., ... of Virtua Health, praised New Jersey Governor Jon Corzine, ... administration for placing a high priority on the health ... budget that was unveiled today in Trenton.In the state ...
Cached Medicine News:Health News:New Editor, New Vision for ACS Surgery 2Health News:New Editor, New Vision for ACS Surgery 3Health News:Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26 2Health News:Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26 3Health News:Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26 4Health News:Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 3Health News:Combo of Tests Might Spot Ovarian Cancer Early 2Health News:Combo of Tests Might Spot Ovarian Cancer Early 3Health News:Virtua Commends Gov. Corzine's Charity Care Funding Plan 2
... 5500s electronic architecture incorporates advanced circuit designs ... it HI VUE an engineering philosophy ... to individual specifications while, at the same ... system. The end result is extraordinary performance ...
... The EG-3630UR is a radial-type endoscope ... new technology gives a flicker-free, high-resolution image ... an optical system for direct visual observation. ... of performance as an endoscope as well ...
... an affordable solution for low volume workloads, ... menu includes a variety of clotting assays, ... ACL 1000 also offers bar code capability ... Plus, it's backed by superior technology that ...
... The SYNCHRON CX4-S system consolidates ... tests in one workstation, targeted ... processes 50-200 samples per day. ... systems, the CX4-S is easy ...
Medicine Products: